{"id":"NCT03514641","sponsor":"Theracos","briefTitle":"An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension","officialTitle":"An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin Tablets, 20 mg, for the Management of Essential Hypertension","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2017-10-18","primaryCompletion":"2018-11-30","completion":"2018-11-30","firstPosted":"2018-05-02","resultsPosted":"2021-09-21","lastUpdate":"2021-09-21"},"enrollment":673,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Essential Hypertension"],"interventions":[{"type":"DRUG","name":"Bexagliflozin","otherNames":["EGT0001442"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Sequence 1","type":"OTHER"},{"label":"Sequence 2","type":"OTHER"},{"label":"Sequence 3","type":"OTHER"},{"label":"Sequence 4","type":"OTHER"}],"summary":"This integrated assessment consists of two studies, 603A and 603B, to be carried out sequentially in a common study population. Participating subjects informed of the trial design and their consent to participate in both studies were to be obtained in a single consent form. Approximately 680 male or female adult subjects were to be enrolled.","primaryOutcome":{"measure":"Change of the 24 Hour Mean Systolic Blood Pressure From Baseline (Day 1) to Week 12","timeFrame":"Baseline (Day 1) to week 12","effectByArm":[{"arm":"Bexagliflozin Tablets, 20 mg","deltaMin":-8.86,"sd":0.642},{"arm":"Placebo Tablets","deltaMin":-6.15,"sd":0.622}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0025"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":87,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":334},"commonTop":["Nasopharyngitis","Urinary tract infection","Upper respiratory tract infection","Pollakiuria","Nausea"]}}